Literature DB >> 24030352

The clinical burden and predictors of sequelae following invasive meningococcal disease in Australian children.

Bing Wang1, Michelle Clarke, Natalie Thomas, Stuart Howell, Hossein Haji Ali Afzali, Helen Marshall.   

Abstract

Of 109 children admitted to a tertiary paediatric hospital with a diagnosis of invasive meningococcal disease from 2000-2011, 37.6% (n = 41) developed sequelae; for serogroup B, 41.3% developed sequelae. Independent predictors of sequelae included: fever ≥ 39 °C on hospital presentation [odds ratio (OR): 4.5; P = 0.012] and a diagnosis of septicemia with meningitis compared with septicemia alone (OR: 15.5; P < 0.001) and meningitis alone (OR: 7.8; P = 0.002).

Entities:  

Mesh:

Year:  2014        PMID: 24030352     DOI: 10.1097/INF.0000000000000043

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  8 in total

1.  Costs of Invasive Meningococcal Disease: A Global Systematic Review.

Authors:  Bing Wang; Renee Santoreneos; Hossein Afzali; Lynne Giles; Helen Marshall
Journal:  Pharmacoeconomics       Date:  2018-10       Impact factor: 4.981

2.  Long-term impact of invasive meningococcal disease in children: SEINE study protocol.

Authors:  Alexiane Baloche; Camille Jung; Michael Levy; Annie Elbez-Rubinstein; Stéphane Béchet; Ines Layouni; Geneviève Monguillot; Muhamed Kheir Taha; Robert Cohen; Corinne Levy
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

Review 3.  Meningococcal disease in childhood: epidemiology, clinical features and prevention.

Authors:  S Bosis; A Mayer; S Esposito
Journal:  J Prev Med Hyg       Date:  2015-08-31

Review 4.  Systematic Review of Invasive Meningococcal Disease: Sequelae and Quality of Life Impact on Patients and Their Caregivers.

Authors:  Kerstin J Olbrich; Dirk Müller; Sarah Schumacher; Ekkehard Beck; Kinga Meszaros; Florian Koerber
Journal:  Infect Dis Ther       Date:  2018-09-28

5.  Healthcare Resource Utilization and Cost of Invasive Meningococcal Disease in Ontario, Canada.

Authors:  Emmanouil Rampakakis; Julie Vaillancourt; Sara Mursleen; John S Sampalis
Journal:  Pediatr Infect Dis J       Date:  2019-03       Impact factor: 2.129

6.  Modeling the public health impact of different meningococcal vaccination strategies with 4CMenB and MenACWY versus the current toddler MenACWY National Immunization Program in Chile.

Authors:  María Gabriela Graña; Gabriel Cavada; Marjorie Vasquez; Jing Shen; Johan Maervoet; Johan Klint; Jorge A Gómez
Journal:  Hum Vaccin Immunother       Date:  2021-12-10       Impact factor: 3.452

7.  Identification of the nasopharyngeal carriage of Neisseria meningitidis by 16S rRNA Gene sequencing in asymptomatic adolescents and young adults in Cartagena, Colombia (2019-2020).

Authors:  Marlon Macias-Mendoza; Alfredo Montes-Robledo; Cindy Arteta-Acosta; Rosa Baldiris-Avila; Wilfrido Coronell-Rodríguez
Journal:  Braz J Infect Dis       Date:  2022-02-15       Impact factor: 3.257

8.  Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease.

Authors:  Stefan Scholz; Magdalena Schwarz; Ekkehard Beck; Kinga Meszaros; Melanie Schneider; Bernhard Ultsch; Wolfgang Greiner
Journal:  Infect Dis Ther       Date:  2021-12-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.